01.10.2024 15:00:29
|
CVS Health: Aetna Unveils 2025 Medicare Plans
(RTTNews) - Aetna, the health insurance arm of CVS Health Corp. (CVS), on Tuesday announced its plan for 2025 Medicare products, including a wide variety of Medicare Advantage or MA plan options, offering value, choice and affordability.
MA plan options would include $0 monthly plan premium, $0 primary care copay, $0 copay for Tier 1 drugs, plus dental, vision, hearing and SilverSneakers benefits in every county it operates.
The 2025 products would include preferred provider organization or PPO products for those who value flexibility; health maintenance organization or HMO products for members focused on affordability; and Special Needs Plans for those who need added support.
The company would also continue to provide an expansive product portfolio, including Medicare Advantage Prescription Drug or MAPD, MA-only, prescription drug plan or PDP, Special Needs Plan or SNP, Medicare Supplement and ancillary products.
For 2025, Aetna will offer MAPD plans in 44 states plus Washington, D.C. In total, Aetna will offer MAPD plans in 2,259 counties in 2025, accessible by 59 million Medicare-eligible beneficiaries.
Aetna now serves about 10.5 million Medicare members across the United States, including 4.3 million currently enrolled in an Aetna individual or employer group MA plan.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
28.01.25 |
Erste Schätzungen: CVS Health stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
24.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte eine CVS Health-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
17.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte ein Investment in CVS Health von vor 5 Jahren bedeutet (finanzen.at) | |
13.01.25 |
Pluszeichen in New York: S&P 500 zum Handelsende fester (finanzen.at) | |
13.01.25 |
Schwache Performance in New York: S&P 500 zeigt sich schwächer (finanzen.at) | |
13.01.25 |
Börse New York in Rot: So steht der S&P 500 am Montagmittag (finanzen.at) | |
13.01.25 |
NYSE-Handel S&P 500 verbucht zum Start des Montagshandels Abschläge (finanzen.at) | |
10.01.25 |
Minuszeichen in New York: S&P 500 präsentiert sich schlussendlich schwächer (finanzen.at) |
Analysen zu CVS Health Corpmehr Analysen
Aktien in diesem Artikel
CVS Health Corp | 54,66 | 0,64% |